| Product NDC: | 13533-635 |
| Proprietary Name: | GamaSTAN S/D |
| Non Proprietary Name: | Immune Globulin (Human) |
| Active Ingredient(s): | .165 g/mL & nbsp; Immune Globulin (Human) |
| Administration Route(s): | INTRAMUSCULAR |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 13533-635 |
| Labeler Name: | Grifols Therapeutics Inc. |
| Product Type: | PLASMA DERIVATIVE |
| FDA Application Number: | BLA101134 |
| Marketing Category: | BLA |
| Start Marketing Date: | 19960814 |
| Package NDC: | 13533-635-10 |
| Package Description: | 10 VIAL in 1 CARTON (13533-635-10) > 10 mL in 1 VIAL (13533-635-13) |
| NDC Code | 13533-635-10 |
| Proprietary Name | GamaSTAN S/D |
| Package Description | 10 VIAL in 1 CARTON (13533-635-10) > 10 mL in 1 VIAL (13533-635-13) |
| Product NDC | 13533-635 |
| Product Type Name | PLASMA DERIVATIVE |
| Non Proprietary Name | Immune Globulin (Human) |
| Dosage Form Name | INJECTION |
| Route Name | INTRAMUSCULAR |
| Start Marketing Date | 19960814 |
| Marketing Category Name | BLA |
| Labeler Name | Grifols Therapeutics Inc. |
| Substance Name | HUMAN IMMUNOGLOBULIN G |
| Strength Number | .165 |
| Strength Unit | g/mL |
| Pharmaceutical Classes | Human Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Antigen Neutralization [MoA],Immunoglobulins [Chemical/Ingredient] |